Iranian
Biomedical Journal
Volume 29, Issue 4 (4-2025)
IBJ 2025, 29(4): 216-227 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hernández Díaz G, Ramírez Nava J C, Aguirre Maldonaldo I, Agame Lagunes B, Cortez Ríos N L, Hernandez Leyva S, et al . Dietary Conjugated Linoleic Acid Isomers Modify the Fatty Acid Composition of Liver and Adipose Tissues. IBJ 2025; 29 (4) :216-227
URL: http://ibj.pasteur.ac.ir/article-1-4990-en.html
URL: http://ibj.pasteur.ac.ir/article-1-4990-en.html
Guillermo Hernández Díaz 
, Julio C. Ramírez Nava , Isaac Aguirre Maldonaldo , Beatriz Agame Lagunes , Narvic L. Cortez Ríos , Sandra Hernandez Leyva , Hugo S. García* , Alfonso Alexander Aguilera *
, Julio C. Ramírez Nava , Isaac Aguirre Maldonaldo , Beatriz Agame Lagunes , Narvic L. Cortez Ríos , Sandra Hernandez Leyva , Hugo S. García* , Alfonso Alexander Aguilera *
Abstract:
Background: Conjugated linoleic acids (CLA) are a group of isomers derived from linoleic acid, naturally present in beef, lamb, and dairy products. CLA has been reported to exert therapeutic effects on cancer, obesity, and diabetes. This study evaluated the effects of a mixture containing equal proportions of CLA isomers (c9,t11 and t10,c12) on insulin resistance (IR) and their incorporation into the plasma membranes of adipocytes and hepatocytes in SHRs.
Methods: For eight weeks, one group of hypertensive rats received sunflower oil supplemented with CLA isomers, while the control group received only vegetable oil. Serum parameters were measured, and the fatty acid composition of plasma membranes was analyzed using gas chromatography.
Results: Rats treated with CLA isomers showed a reduction in body weight (BW), IR, and hypertension. Additionally, there was a significant incorporation of CLA into the plasma membranes of adipocytes and hepatocytes. In contrast, the control rats displayed higher levels of n-6 polyunsaturated fatty acid and arachidonic acid (AA) in their membranes, which promote the synthesis of eicosanoids and hypertensive prostaglandins. These findings were further supported by data mining analysis, which linked the results to the expression levels of genes encoding enzymes involved in the synthesis of PGE2, D2, and F2α from AA.
Conclusion: The mixture of CLA isomers reduced BW, IR, and hypertension in SHRs. These effects were associated with the incorporation of c9,t11 and t10,c12 isomers into the plasma membranes of adipocytes and hepatocytes.
Methods: For eight weeks, one group of hypertensive rats received sunflower oil supplemented with CLA isomers, while the control group received only vegetable oil. Serum parameters were measured, and the fatty acid composition of plasma membranes was analyzed using gas chromatography.
Results: Rats treated with CLA isomers showed a reduction in body weight (BW), IR, and hypertension. Additionally, there was a significant incorporation of CLA into the plasma membranes of adipocytes and hepatocytes. In contrast, the control rats displayed higher levels of n-6 polyunsaturated fatty acid and arachidonic acid (AA) in their membranes, which promote the synthesis of eicosanoids and hypertensive prostaglandins. These findings were further supported by data mining analysis, which linked the results to the expression levels of genes encoding enzymes involved in the synthesis of PGE2, D2, and F2α from AA.
Conclusion: The mixture of CLA isomers reduced BW, IR, and hypertension in SHRs. These effects were associated with the incorporation of c9,t11 and t10,c12 isomers into the plasma membranes of adipocytes and hepatocytes.
Type of Study: Full Length/Original Article |
Subject:
Related Fields
References
1. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Research. 2001;40(4):283-98. [DOI:10.1016/S0163-7827(01)00008-X]
2. Eulitz K, Yurawecz MP, Sehat N, Fritsche J, Roach JA, Mossoba MM, et al. Preparation, separation, and confirmation of the eight geometrical cis/trans conjugated linoleic acid isomers 8,10- through 11,13-18:2. Lipids. 1999;34(8):873-7. [DOI:10.1007/s11745-999-0435-z]
3. Park Y, Pariza MW. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Res Int. 2007;40(3):311-23. [DOI:10.1016/j.foodres.2006.11.002]
4. Parodi PW. Conjugated octadecadienoic acids of milk-fat. J Dairy Sci. 1977:60:1550-3. [DOI:10.3168/jds.S0022-0302(77)84068-X]
5. Ip C, Scimeca JA, Thompson HJ. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer. 1994;74(3):1050-4.
https://doi.org/10.1002/1097-0142(19940801)74:3+<1050::AID-CNCR2820741512>3.0.CO;2-I [DOI:10.1002/1097-0142(19940801)74:3+3.0.CO;2-I]
6. Nagao K, Wang YM, Inoue N, Han SY, Buang Y, Noda T, et al. The 10trans, 12cis isomer of conjugated linoleic acid promotes energy metabolism in OLETF rats. Nutrition. 2003;19(7-8):652-6. [DOI:10.1016/S0899-9007(03)00060-1]
7. Lee KN, Kritchevsky D, Pariza MW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis. 1994;108(1):19-25. [DOI:10.1016/0021-9150(94)90034-5]
8. Houseknecht KL, Vanden-Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 1998;244(3):678-82. [DOI:10.1006/bbrc.1998.8303]
9. Nagao K, Inoue N, Wang YM, Hirata J, Shimada Y, Nagao T, et al. The 10trans,12cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun. 2003;306(1):134-8. [DOI:10.1016/S0006-291X(03)00929-X]
10. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006;17(12):789-810. [DOI:10.1016/j.jnutbio.2006.02.009]
11. Clement L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, et al. Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res. 2002;43(9):1400-9. [DOI:10.1194/jlr.M20008-JLR200]
12. Yang T, Du Y. Distinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulation. Am J Hypertens. 2012;25(10):1042-9. [DOI:10.1038/ajh.2012.67]
13. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36(9):1007-24. [DOI:10.1007/s11745-001-0812-7]
14. Pariza MW, Park Y, Cook ME. Mechanism of action of conjugated linoleic acid: Evidence and speculation. Proc Soc Exp Biol Med. 2000;223(1):8-13. [DOI:10.1111/j.1525-1373.2000.22302.x]
15. Kong D, Yu Y. Prostaglandin D2 signaling and cardiovascular homeostasis. J Mol Cell Cardiol. 2022:167:97-105. [DOI:10.1016/j.yjmcc.2022.03.011]
16. Yu Y, Lucitt MB, Stubbe J, Cheng Y, Friis UG, Hansen BP, et al. Prostaglandin F2α elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci USA. 2009;106(19):7985-90. [DOI:10.1073/pnas.0811834106]
17. Aluja AS. Mexican Official Standard, NOM-062-ZOO-1999, Technical specifications for the production, care and use of laboratory animals. Gac Med Mex. 2002;138(3):295-8.
18. National Research Council. Guide for the care and use of laboratory animals. 8th Edition. Washington: National Academic Press; 2011.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985:28:412-9. [DOI:10.1007/BF00280883]
20. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method of assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402-10. [DOI:10.1210/jcem.85.7.6661]
21. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care. 2003;26(8):2426-32. [DOI:10.2337/diacare.26.8.2426]
22. Belsham GJ, Denton RM, Tanner MJ. Use of a novel rapid preparation of fat-cell plasma membranes employing Percoll to investigate the effects of insulin and adrenaline on membrane protein phosphorylation within intact fat-cells. Biochem J. 1980;192(2):457-467. [DOI:10.1042/bj1920457]
23. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res. 1964:5:600-8. [DOI:10.1016/S0022-2275(20)40190-7]
24. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. [DOI:10.1126/science.1260419]
25. Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397-406. [DOI:10.1074/mcp.M113.035600]
26. Wang YW, Jones PJH. Conjugated linoleic acid and obesity control: Efficacy and mechanisms. Int J Obes Relat Metab Disord. 2004;28(8):941-55. [DOI:10.1038/sj.ijo.0802641]
27. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: Evidence from animal and human studies. J Lipid Res. 2003;44(12):2234-41. [DOI:10.1194/jlr.R300011-JLR200]
28. Navarro V, Zabala A, Macarulla MT, Fernández Quintela A, Rodríguez VM, Simón E, et al. Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. J Physiol Biochem. 2003;59(3):193-9. [DOI:10.1007/BF03179915]
29. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 2000;49(9):1534-42. [DOI:10.2337/diabetes.49.9.1534]
30. Asbaghi O, Shimi G, Hosseini Oskouie F, Naseri K, Bagheri R, Ashtary-Larky D, et al. The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: A systematic review and dose-response meta-analysis. Br J Nutr. 2024;131(3):406-28. [DOI:10.1017/S0007114523001861]
31. Dilzer A, Park Y. Implication of conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci Nutr. 2012,52(6):488-513. [DOI:10.1080/10408398.2010.501409]
32. Inoue N, Nagao K, Hirata J, Wang Y-M, Yanagita T. Conjugated linoleic acid prevents the development of essential hypertension in spontaneously hypertensive rats. Biochem Biophys Res Commun. 2004;323(2):679-84. [DOI:10.1016/j.bbrc.2004.08.139]
33. DeClercq V, Taylor CG, Wigle J, Wright B, Tworek L, Zahradka P. Conjugated linoleic acid improves blood pressure by increasing adiponectin and endothelial nitric oxide synthase activity. J Nutr Biochem. 2012:23:487-93. [DOI:10.1016/j.jnutbio.2011.02.003]
34. Zhao WS, Zhai JJ, Wang YH, Xie PS, Yin XJ, Li LX, et al. Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension. Am J Hypertens. 2009;22(6):680-6. [DOI:10.1038/ajh.2009.56]
35. Engberink MF, Geleijnse JM, Wanders AJ, Brouwer IA. The effect of conjugated linoleic acid, a natural transfat from milk and meat, on human blood pressure: Results from a randomized crossover feeding study. J Hum Hypertens. 2012;26(2):127-32. [DOI:10.1038/jhh.2010.132]
36. DeClercq V, Taylor C, Zahradka P. Adipose tissue: The link between obesity and cardiovascular disease. Cardiovasc Hematol Disord Drug Targets. 2008;8(3):228-37. [DOI:10.2174/187152908785849080]
37. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol. 2004;287(4):943-9. [DOI:10.1152/ajpregu.00265.2004]
38. Nagao K, Inoue N, Wang Y-M, Yanagita T. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem Biophys Res Commun. 2003;310(2):562-6. [DOI:10.1016/j.bbrc.2003.09.044]
39. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J-I, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 2012;425(3):560-4. [DOI:10.1016/j.bbrc.2012.08.024]
40. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285(3):527-33. [DOI:10.1152/ajpendo.00110.2003]
41. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertens. 2006;47(6):1108-16. [DOI:10.1161/01.HYP.0000222368.43759.a1]
42. Noto A, Zahradka P, Yurkova N, Xie X, Truong H, Nitschmann E, et al. Dietary conjugated linoleic acid decreases adipocyte size and favorably modifies adipokine status and insulin sensitivity in obese, insulin-resistant rats. Metabolism. 2007;56(12):1601-11. [DOI:10.1016/j.metabol.2007.06.025]
43. Yang J, Wang H-P, Zhou L-M, Zhou L, Chen T, Qin L-Q. Effect of conjugated linoleic acid on blood pressure: A meta-analysis of randomized, double-blind placebo-controlled trials. Lipids Health Dis. 2015:14:11 [DOI:10.1186/s12944-015-0010-9]
44. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003;42(3):231-4. [DOI:10.1161/01.HYP.0000083488.67550.B8]
45. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46(12):2040-3. [DOI:10.2337/diab.46.12.2040]
46. Moloney F, Yeow T-P, Mullen A, Nolan JJ, and Helen Roche HM. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004;80(4):887-95. [DOI:10.1093/ajcn/80.4.887]
47. Park Y, Albright KJ, Storkson JM, Liu W, Pariza MW. Conjugated linoleic acid (CLA) prevents body fat accumulation and weight gain in an animal model. J Food Sci. 2007;72(8):612-7 [DOI:10.1111/j.1750-3841.2007.00477.x]
48. Takahashi Y, Kushiro M, Shinohara K, Ide T. Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. Biochim Biophys Acta. 2003;1631(3):265-73. [DOI:10.1016/S1388-1981(03)00038-6]
49. Moya-Camarena SY, Van den Heuvel JP, Belury MA. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim Biophys Acta. 1999;1436(3):331-42. [DOI:10.1016/S0005-2760(98)00121-0]
50. Seo MJ, Oh DK. Prostaglandin synthases: Molecular characterization and involvement in prostaglandin biosynthesis. Prog Lipid Res. 2017:66:50-68. [DOI:10.1016/j.plipres.2017.04.003]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |